Treść książki

Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
8
4.
Spistreści
3.2.1.Hemodynamicznekonsekwencjekrwotokulllllllllllllllllllllllll201
3.2.2.Obrazklinicznywstrząsulllllllllllllllllllllllllllllllllllllllllll203
3.3.
Rozpoznanieimonitorowaniewstrząsukrwotocznegollllllllllllll205
3.3.1.Ocenaobjętościutraconejkrwilllllllllllllllllllllllllllllllllllll205
3.3.2.Monitorowaniehemodynamicznelllllllllllllllllllllllllllllllllll205
3.3.3.Ocenaperfuzjitkankowejlllllllllllllllllllllllllllllllllllllllllll206
3.3.4.Badanialaboratoryjnellllllllllllllllllllllllllllllllllllllllllllll207
3.4.
Leczeniewstrząsukrwotocznegolllllllllllllllllllllllllllllllllll207
3.4.1.Postępowaniepołożniczelllllllllllllllllllllllllllllllllllllllllll207
3.4.2.Resuscytacjakrążeniallllllllllllllllllllllllllllllllllllllllllllll208
3.4.3.Przetaczaniekrwiijejpreparatówlllllllllllllllllllllllllllllllll213
3.4.4.Leczeniezaburzeńkrzepnięciallllllllllllllllllllllllllllllllllllll215
3.4.5.Rekombinowanyaktywowanyczynnik
krzepnięciaVIIa(rFVIIa)lllllllllllllllllllllllllllllllllllllllllll216
3.4.6.Pozostałeelementyterapiillllllllllllllllllllllllllllllllllllllllll217
3.4.7.Permisywnahipotensjatętniczallllllllllllllllllllllllllllllllllll218
3.5.
Anestezjawprzypadkukrwotokupołożniczegolllllllllllllllllllll219
Wstrząsseptycznylllllllllllllllllllllllllllllllllllllllllllllllllllllllll223
4.1.
Definicjaiepidemiologiallllllllllllllllllllllllllllllllllllllllllll223
4.1.1.Definicjestanówseptycznychlllllllllllllllllllllllllllllllllllllll223
4.1.2.Epidemiologiaiśmiertelnośćlllllllllllllllllllllllllllllllllllllll226
4.2.
Etiopatogenezalllllllllllllllllllllllllllllllllllllllllllllllllllll226
4.2.1.Czynnikietiologicznelllllllllllllllllllllllllllllllllllllllllllllll226
4.2.2.Mediatorywstrząsullllllllllllllllllllllllllllllllllllllllllllllll227
4.2.3.Wstrząsseptycznyizespółuogólnionejodpowiedzi
zapalnej(SIRS)lllllllllllllllllllllllllllllllllllllllllllllllllllll228
4.3.
Zaburzenianarządowewprzypadkuwstrząsuseptycznegolllllllll229
4.3.1.Układkrążenialllllllllllllllllllllllllllllllllllllllllllllllllllll229
4.3.2.Innenarządylllllllllllllllllllllllllllllllllllllllllllllllllllllll230
4.3.3.Wstrząsseptycznyipłódlllllllllllllllllllllllllllllllllllllllllll231
4.4.
Rozpoznanieimonitorowaniellllllllllllllllllllllllllllllllllllll231
4.5.
Resuscytacjaukładukrążenialllllllllllllllllllllllllllllllllllllll234
4.5.1.Objętośćprzetaczanychpłynówlllllllllllllllllllllllllllllllllllll236
4.5.2.Rodzajprzetaczanychpłynówllllllllllllllllllllllllllllllllllllll237
4.5.3.Przywrócenieciśnieniaperfuzjilllllllllllllllllllllllllllllllllllll237
4.5.4.Aminykatecholowelllllllllllllllllllllllllllllllllllllllllllllllll238
4.5.5.Wazopresynalllllllllllllllllllllllllllllllllllllllllllllllllllllll240
4.6.
Antybiotykoterapialllllllllllllllllllllllllllllllllllllllllllllllll241
4.7.
Modulacjaodpowiedzizapalnejlllllllllllllllllllllllllllllllllllll243
4.7.1.Glikokortykosteroidylllllllllllllllllllllllllllllllllllllllllllllll244
4.7.2.Kontrolaglikemiilllllllllllllllllllllllllllllllllllllllllllllllllll245
4.7.3.Innelekiimmunomodulującelllllllllllllllllllllllllllllllllllllll246
4.8.
Pozostałeelementyterapiillllllllllllllllllllllllllllllllllllllllll246
4.8.1.Leczeniezaburzeńoddychaniallllllllllllllllllllllllllllllllllllll246
4.8.2.Leczenieżywieniowelllllllllllllllllllllllllllllllllllllllllllllll247
4.8.3.Terapianerkozastępczalllllllllllllllllllllllllllllllllllllllllllll248
4.8.4.Zaburzeniakrzepnięcialllllllllllllllllllllllllllllllllllllllllllll248
4.9.
Zespółwstrząsutoksycznegolllllllllllllllllllllllllllllllllllllll249
4.9.1.Etiopatogezalllllllllllllllllllllllllllllllllllllllllllllllllllllll249
4.9.2.Rozpoznanielllllllllllllllllllllllllllllllllllllllllllllllllllllll250
4.9.3.Leczeniellllllllllllllllllllllllllllllllllllllllllllllllllllllllllll250